https://peptide.town/story/employers-dropping-glp-1-coverage-workersPeptide Townen2026-11-01T04:44:00.000ZEmployers dropping GLP 1 coverage push weight loss costs onto workers https://peptide.town/story/bpc-157-compounding-pharmacy-pathPeptide Townen2026-11-01T04:15:00.000ZBPC 157 compounding gets a pharmacy path while human proof stays thin https://peptide.town/story/lilly-q3-earnings-lower-net-pricesPeptide Townen2026-10-30T05:46:00.000ZLilly Q3 earnings show Zepbound and Mounjaro selling more at lower net prices